Capital Group Private Markets
VC Fund
Beijing, China
Capital Group Private Markets is a VC fund in Beijing focused on Beauty and Retail. Founded in 1992, Capital Group Private Markets has invested over $5 billion in more than 80 companies across global emerging markets from its six emerging markets private equity funds. Capital Group Private Markets is an experienced leader in emerging markets private equity and a pioneer of the global approach to building a diversified emergingmarkets portfolio. As an active investor across Latin America, Capital Group Private Markets has been investing in Colombia for over 15 years.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Capital Group Private Markets invests in
Stages Capital Group Private Markets invests in
Countries Capital Group Private Markets invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Leonard Kim
|
|||
Nick Chen
|
|||
Investment Focus
Industry
- Beauty 1 (25%)
- Retail 1 (25%)
- Internet 1 (25%)
- Biopharma 1 (25%)
- Cosmetics 1 (25%)
Stage
- Series C 1 (25%)
- Series E 1 (25%)
- Secondary Market 1 (25%)
Country
- China 1 (25%)
- Colombia 1 (25%)
- United States 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Leonard Kim
Managing partner
|
Managing partner | Total investments: 1 | Find email | |
|
Nick Chen
Partner
|
Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
RealSelf
|
RealSelf brings transparency to the elective medical & aesthetic treatment market which represents a wide range of services—from a simple skin treatment to cosmetic surgery. At the heart of RealSelf is a community of people sharing personal experiences, unbiased stories, and candid advice. Thousand of medical experts also participate onRealSelf. Doctors and clinicians have posted over two million answers to questions and routinely upload educational videos, special offers, and patient before & after photos. | Series C / Aug 10, 2018 | |
Innovent Biologics
|
Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others. | $150M / Series E / Apr 27, 2018 | |
|
Innovent Biologics
|
Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others. | $150M / Series E / Apr 27, 2018 | |
D1 Stores
|
Koba International Group is a Colombian retailer with around 500 stores. | Secondary Market / Sep 12, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Capital Group Private Markets invest in?
Capital Group Private Markets invests primarily in Beauty, Retail and Internet startups, most often at Series C and Series E stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Capital Group Private Markets?
Public channels for Capital Group Private Markets include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Capital Group Private Markets?
The team at Capital Group Private Markets includes Leonard Kim (Managing partner) and Nick Chen (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
